Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for phosphodiesterase type 5 inhibitor (compound)
Most Correlated Studies
- Quadriceps from DMD[mdx/mdx] mice treated with Tadalafil
- Cystic fibrosis bronchial epithelial cells expressing mutant CFTR and treated with small molecules
- Livers of rat exposed to variety of hepatotoxic compounds
- Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- PDE5 inhibitor drugs for use in dementia.
- Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health.
- Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism…
- PDE5 inhibitors and male reproduction: Is there a place for PDE5 inhibitors in infertility clinics o…
- PDE5 inhibitors: breaking new grounds in the treatment of COVID-19.
Most Relevant Clinical Trials
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
- Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Dis…
- Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults
- Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
- A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (…
